The symposium titled: “The Role of QP – The Paradigm for the
21st Century” was held in conjunction with the MSc in Pharmaceutical
Technology & Quality Systems programme established by UCC’s School of
Pharmacy in 2007 with support from Amgen, to meet the growing demand for QP in
the pharmaceutical sector in Ireland.
Keynote speakers included: Ms Valerie
Mulholland, Founder and Senior Consultant at GMP services, Dr Colman Casey,
Director of Research, College of Medicine & Health, UCC; Mr Stan O’Neill, Managing
Director at The Compliance Group and Mr Paul Sexton, GMP Manager, Irish
Medicines Board.
Dr Brendan Griffin, Programme Director, said the symposium was of
significant interest to industry-based pharmaceutical scientists as the event
included both keynote speakers and workshops highlighting manufacturing &
quality issues in the modern pharmaceutical/biopharmaceutical manufacturing
environment.
The MSc programme at UCC represents a key element of the interaction
between the School of Pharmacy and
pharmaceutical companies, helping to develop collaborations and serving to
enhance the mutual interests of UCC and the pharmaceutical industry – which is
particularly relevant in light of the changes in the Irish industry with greater
emphasis on the higher value ‘knowledge-led’ processing operations, such as
R&D and specialised pharmaceutical processing, with less reliance on bulk
manufacture.
Further information on the QP symposium, including programme of events
and information booklet, is available on http://www.ucc.ie/en/pharmacy/Events/
1344MMcS
<<Previous ItemNext Item>>
« Back to 2010 Press Releases
